Concepedia

Jonathan R. Young

JR

44

Publications

2.3K

Citations

26

H-Index

1973

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of California, Los Angeles

Ronald Reagan UCLA Medical Center

University of California, Davis

Jonathan R. Young is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1973–2021

44

Publications

44

Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment

Whitney B. Pope, Grace Hyun J. Kim, Jing Huo et al. · Radiology · 2009 · 317 citations

Clear Cell Renal Cell Carcinoma: Discrimination from Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CT

Jonathan R. Young, Daniel Margolis, Steven Sauk et al. · Radiology · 2013 · 305 citations

Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

Whitney B. Pope, Albert Lai, Rupal I. Mehta et al. · American Journal of Neuroradiology · 2011 · 178 citations · Full text

Antihypertensive agents. Synthesis and biological properties of 2-amino-4-aryl-2-imidazolines

W. L. Matier, D. Alfred Owens, William T. Comer et al. · Journal of Medicinal Chemistry · 1973 · 133 citations

, , +13

Qualitative and Quantitative MDCT Features for Differentiating Clear Cell Renal Cell Carcinoma From Other Solid Renal Cortical Masses

Stephanie Lee‐Felker, Ely Felker, Nelly Tan et al. · American Journal of Roentgenology · 2014 · 128 citations

Rows per page

1–5 of 44